PathAI
AI-powered pathology platform using machine learning to enhance the accuracy and efficiency of disease diagnosis, with a focus on cancer detection and precision medicine.
Website
https://www.pathai.comLocation
Boston, Massachusetts, USA
Founded
2016
Investors
1
Categories
ai, pathology, diagnostics, oncology, machine-learning
Notes
PathAI is an AI-powered pathology company that uses machine learning to improve the accuracy and efficiency of disease diagnosis. The company's platform analyzes pathology images to assist pathologists in detecting cancer and other diseases with greater precision and consistency.
PathAI partners with pharmaceutical companies and healthcare institutions to develop and deploy AI-powered diagnostic tools that support clinical decision-making and drug development.
Team
- Andy Beck, M.D., Ph.D. - Co-Founder & Chief Executive Officer
- LinkedIn: linkedin.com/in/andybeck
- Aditya Khosla, Ph.D. - Co-Founder & President
Additional Research Findings
- Founded in 2016 in Boston, Massachusetts
- Portfolio company of Polaris Partners
- AI/ML platform for pathology image analysis
- Partnerships with Bristol-Myers Squibb, Gilead, and other pharma companies
- Focus on cancer detection and precision medicine
- Clinical decision support for pathologists
- Applications in drug development and companion diagnostics
- One of the leading AI pathology companies
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Polaris Partners | US | biotech-focused | - | 33 |